Product information and disease descriptionPlace of product in therapyDisease description
Clinical presentation - signs and symptoms
18 evidence topics · 6 sources
Age-dependent presentation: visceral in infancy, neurological from late infancy onward
Hepatic and visceral symptoms: neonatal cholestasis and hepatosplenomegaly in the pre/perinatal period
“Statement #4: NPC primarily manifests in the pre/perinatal age group as liver disease presenting with prolonged cholestatic jaundice, hepatosplenomegaly, and in some cases fetal hydrops or ascites and acute liver failure, with or without pulmonary disease.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In most cases, jaundice resolves spontaneously by 3–4 months of age, while organomegaly persists to variable degrees.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Hepatic and visceral symptoms: frequency of splenomegaly, hepatomegaly, and neonatal jaundice in the International Niemann-Pick Disease Registry
“Here we report NPC patient data from the International Niemann-Pick Disease Registry (INPDR).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The proportion of patients who developed splenomegaly was 72.8%, whilst hepatomegaly was reported in 39.5% of patients.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Similarly, neonatal jaundice was noted in 39.5% of patients, and hepatic failure in the neonatal period was 6.2%.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The proportion of patients with neonatal jaundice, spleno- and hepatomegaly decreased with increasing age of neurological onset.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Hepatic and visceral symptoms: neonatal liver disease and earlier neurological onset in 93 individuals with NPC1
“Liver disease was characterized in 93 individuals with NPC1 using FibroScan, abdominal ultrasound, and plasma liver function tests at baseline and longitudinally over up to a four-year period.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Those with no history of neonatal liver disease had an average age of 10.3 years at time of neurological symptoms, compared to 5.9 years for those with mild/moderate disease and 3.6 years for those with severe disease (p = 0.002).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Respiratory symptoms: pulmonary foam-cell infiltration in infancy
Motor and developmental symptoms: hypotonia and delayed motor milestones in early infantile onset
“Statement #5: Hypotonia and delay in developmental motor milestones characterize the neurological manifestation of NPC in early infancy. Hepatosplenomegaly and/or prolonged neonatal jaundice are almost invariably noted, although cases with severe hypotonia in early infancy without obvious visceral disease can occur. Pulmonary disease may also be present.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Motor and developmental symptoms: early infantile onset in a French cohort
“Data available on all NP-C patients with early infantile neurological onset diagnosed in France between 1990 and 2013 were compiled.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“All patients in the present EI-NP-C series began neurological symptoms before 18 months of age” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“only few patients temporarily acquired autonomous walking, and none did acquire a fully normal gait.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Hypotonia and motor development delay were the first neurological sign in 85% of the patients, ataxia, and psychomotor regression in the remaining 15%.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Motor and developmental symptoms: clumsiness, gait disturbance, and speech delay in late infantile onset
“Statement #6: Clumsiness, gait disturbance, and fine motor skill impairments characterize this age of disease onset. Speech delay, a history of neonatal cholestasis, seizures, pulmonary disease, variable visceromegaly, and failure to reach or loss of developmental milestones may be noted.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Motor and developmental symptoms: developmental milestone delay by age at neurological onset in the registry
“Of the 46 patients where data is available, the most common manifestations were delay/impairments in: cognition (69.6%), speech (60.9%), motor (60.9%) and social (45.7%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In respect to neurological classification, speech delay was most common in early infantile (91.7%), whilst cognitive impairment was most common in late infantile (78.9%) and adult (100%), with motor delay (33.3%) and cognitive impairment (33.3%) predominant in juvenile onset.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Neurological symptoms: frequency of neurological manifestations in the registry
“The most common neurological manifestations reported include cognitive impairment (78.5%), dysarthria (75.9%), ataxia (75.9%), vertical supranuclear gaze palsy (VSGP) (70.9%), dysphagia (69.6%), dystonia (53.2%), seizures (48.1%), and cataplexy (35.4%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Overall, the late infantile onset subgroup made up the highest proportion of neurological manifestations, with the exception of psychiatric manifestations and cognitive impairment.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The least prevalent neurological manifestations were psychiatric manifestations (13.9%) and hearing impairment (7.6%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Oculomotor symptoms: vertical supranuclear saccadic palsy and gaze palsy
“Vertical supranuclear saccadic palsy (VSSP), followed later by vertical supranuclear gaze palsy (VSGP), is typically present but often unrecognized.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Seizures and gelastic cataplexy
Movement disorder and bulbar symptoms: dystonia, dysarthria, and dysphagia
Auditory symptoms: hearing loss in 50 patients with NPC1
“Data from 50 patients with NPC1 confirm a prevalent, often high frequency, hearing loss that is progressive in at least some individuals.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Retrocochlear involvement is common, and some patients present with a profile of auditory neuropathy spectrum disorder.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Moreover, of the 31 patients with behavioral data, 23 (74%) presented with clinically significant hearing loss involving the frequencies most important to speech understanding (500–4000 Hz).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Auditory symptoms: sensory deafness as a first symptom in late infantile onset
Cognitive symptoms: progressive cognitive impairment in childhood
Cognitive and psychiatric symptoms: juvenile and adult onset
“Statement #7: Juvenile onset manifests as cognitive impairment (lagging behind peers in school, language and learning difficulties), coordination problems (clumsiness, frequent falls, progressive ataxia, and dystonia), seizures, and VSGP.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Cognitive impairment invariably occurs and tends to present with higher rates of psychiatric illness alongside neurological manifestations.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote